Zap and Go have created ultra fast technology for cordless and hand held devices by using Carbon-Ion technology which result in ultra-fast charging, taking 5 minutes or less. The technology is part derived from Oxford University and in part developed independently by Zap&Go's own scientists.
days to go:
Expired
investment:
£1,353,551
VoxSmart is a global mobile technology company focused on achieving compliance in a very heavy regulated industries such as finance and banking. VoxSmart software is embedded on the mobile device and allows the capturing and recording of all communications on that device
days to go:
Expired
investment:
£3,857,500
Kaleao has created simple, agile and flexible hardware and software systems which provide 10x more performance per unit of space and consumes 4x less energy. They maintain all promises of the hyperconvergence through the convergence of compute, storage and networking hardware whilst teamed with a full-featured and flexible software platform.
days to go:
Expired
investment:
£2,050,000
Publisher Discovery, using AI & Machine Learning technologies, provides recommendations to Advertisers of highly relevant Publishers in the affiliate marketing sector. The company has built a uniquely curated database of over 2 million publishers and 330,000 advertisers, which are then analysed, compared, and matched to make recommendations in ranked lists, matching the best publishers with each advertiser. The affiliate publishing market is worth 16 billion dollars per year but is still largely dominated by human-based agencies and is uniquely suited for automation. Publisher Discovery aims to capitalise on this aspect and establish itself as the market leader. The company has signed up over 50 publishers and is negotiating contracts with two large distribution partners. It is currently raising £1 million investment with £675,000 committed so far, to grow sales and operations and reach over £2m Annual Recurring Revenue (ARR) in the following 12 months.
days to go:
Expired
investment:
£800,000
The Face Recognition Company (FRC) produces 90%+ accurate face recognition solution. In 2016, the company came up with the objective to develop the most accurate and cost-effective facial recognition solution. This technology is suitable for commercial applications or crime and other security uses. Additionally, the FRC's go-to-market strategy incorporates working through large integrators/partners/approved installers, eight of which are ready to promote and install its product to their own customer base. The FRC team has technically developed this solution by combining 100 years of experience in facial recognition. In June 2018, FRC had filed for two patents: first, ‘Recognition of 3D Objects’ and second, 'Method of and System for Recognising a Human Face’. Where suitable, FRC has also set-up an EIS tax relief.
days to go:
Expired
investment:
£215,600
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go:
Expired
investment:
Withheld
Zone V makes the latest tablets and smartphones work for the older generation with low eyesight, deficient hearing or dexterity. The company has redefined a global platform that is providing access to the services that are difficult to use. They have a technological partnership with Samsung and are a Samsung Managed Solutions Partner. The company also creates inclusively accessible technology, services, and applications for more smoother and viable communication. The executive team of this company includes health, telecoms, and wellness fields. With the proceeds, Zone V will widen the digital divide for the older smartphones users by working tirelessly to build new innovative communication solutions.
days to go:
Expired
investment:
£500,000
Ancon is designed to detect trace elements of things such as explosives, drugs and chemical weapons in the air. Ancon manufactures equipment and components that are up to 10,000 times more sensitive then anything else on the market.
days to go:
Expired
investment:
£1,043,525
3DUserNet is an online portal for viewing and collaborating on 3D data projects. Its SaaS platform enables team members in engineering and construction companies to store, view, navigate and collaborate online, through any modern browser or device, without the need for installed software. The company has been working with sectors such as surveying, policing, civil engineering, security, road safety, and defence. Since its inception, it has added multiple measurement tools including clip boxes, line of sight, checkpoint tool, and slope tool on its platform. The company is seeking an investment of up to £400,000, at a pre-money valuation of £1.6 million under which it is offering investors making up the first £200,000 a discounted share price of £3.4733. Investors joining in for the remaining £200,000 thereafter will purchase a share for £4.6622. The funds raised will be used for further platform development, sales and marketing, and working capital.
days to go:
Expired
investment:
Withheld
Iceni Labs is an innovative enterprise that develops and deploys cutting-edge technologies to build a safer and secure future. The company takes early-stage technology from the lab to the market by partnering with leading academics, researchers, and commercial experts. It has collaborated with the UK National Health Service’s (NHS) Royal Papworth Hospital to accelerate the development of a non-contact device, SafeScan, that monitors the breathing rate of an individual remotely. Iceni Labs also conducted a one-year clinical study of the device at Royal Papworth Hospital on a sample size of 400 patients. It has been awarded Innovate UK funding to build a prototype for monitoring care home residents. The company's goal is to become globally recognised as a catalyst for successful innovation.
days to go:
Expired
investment:
Withheld
